[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100459548":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":40,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"University of Chicago","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Omar Jamil, MD","CONTACT","847-373-2360","Omar.Jamil@uchospitals.edu",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Maria Newsome","773-702-2788","mnewsome1@bsd.uchicago.edu",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"The University of Chicago","RECRUITING","Chicago","Illinois","60637","United States",{"type":27,"coordinates":28},"Point",[29,30],-87.65005,41.85003,{"lat":30,"lon":29},[33,34,37],{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},{"name":35,"role":11,"phone":36,"phoneExt":7,"email":13},"Omar Jamal, MD","773-702-0309",{"name":38,"role":39,"phone":7,"phoneExt":7,"email":7},"Michael Charlton, MD","PRINCIPAL_INVESTIGATOR",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100459548",false,"NCT05264051","MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease","Inclusion Criteria:\n\n* Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated\n\nExclusion Criteria:\n\n* \\\u003C18 yrs. of age","ALL","18 Years",{"count":50,"type":51},1200,"ESTIMATED","OBSERVATIONAL","The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.",[55],"Liver Diseases","2026-01-12",{"date":58,"type":59},"2026-01-14","ACTUAL",{"date":61,"type":59},"2022-04-18",{"date":63,"type":51},"2027-03-01",{"name":5,"class":6},1]